Bonus BioGroup Company Description

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy.

The company’s products in development include BonoFill for bone tissue regeneration in maxillofacial and orthopedic indications and is in Phase II clinical trial; and MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS and is in phase III trial.

Its products in pipeline also comprise BonoFill for bone augmentation in osteoporosis patients; MesenCure for treating other inflammations and tissue damage; vascularized bone grafts; and soft tissue grafts.

The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is based in Haifa, Israel.

Bonus BioGroup Ltd.

Country	Israel
Founded	1981
Industry	Biotechnology
Sector	Healthcare
Employees	58
CEO	Shai Meretzki

Contact Details

Address: 20 Madain Industries Center Haifa, 3190501 Israel
Phone	972 7 3206 7100
Website	bonus-bio.com

Stock Details

Ticker Symbol	BONS
Exchange	Tel Aviv Stock Exchange
Fiscal Year	January - December
Reporting Currency	ILS
ISIN Number	IL0004850116
SIC Code	2836

Key Executives

Name	Position
Dr. Shai Meretzki Ph.D.	Founder, Chief Executive Officer, President and Director
Joseph Rauch M.B.A.	Executive Chairman of the Board
Yoni Livne CPA	Chief Financial Officer
Dr. Dror Ben David Ph.D.	Chief Operations Officer
Dr. Vered Kivity M.B.A., Ph.D.	Head of Regulatory Affairs and Vice President of Clinical Affairs